Friday, August 22, 2014
Inquirer Daily News

Tales from DIA: A new world of personalized, patient-centric medicine

Tuesday, June 24, 2014, 4:04 PM
My latest melanoma adventure has me in San Diego for back-to-back conferences over 10 days in two overlapping industries. It’s a long time to be away from the family, especially with a bit of the unknown hanging over us from the last scan – Tony Gwynn passing away from cancer the day I... Read more

How golf outings, walks, and runs are giving life to others

Thursday, June 19, 2014, 4:25 PM
Susan Fazio and Peggy Spiegler, two ladies I never met, have made an impact on my melanoma battle. Plus, we have a few things in common. First, they were local gals, Susan from Blue Bell, Peggy from Cherry Hill. They were also a generation ahead of me, but their kids and I are the same age –... Read more

Tales from ASCO: The future of cancer research

Wednesday, June 18, 2014, 11:14 AM
ASCO 2014 was more than just big headlines – press releases trickled in for the entire week afterwards, and while the major announcements hit the wires in real time, the smaller findings and stories had their time to shine, too. Here is a little more insight about the future of cancer research... Read more

Tales from ASCO: Q&A with MRA’s Chief Science Officer Louise Perkins

Thursday, June 12, 2014, 10:07 AM
What do you do when you step into a pool of 33,000 cancer experts at the annual American Society of Clinical Oncology meeting and your scientific knowledge lies right around #32,995 on that list? (I had to know more than at least five people at that conference, right?) Well, I’ll tell you what... Read more

The rookie’s guide to navigating the 2014 ASCO annual meeting

Thursday, June 5, 2014, 12:46 PM
I was prepared to be overmatched medically speaking when I walked into ASCO’s 2014 annual meeting; but I definitely was not prepared for the few hours it took me just to get caught up the “overmatched” level I had anticipated. So, with that in mind, follow along with my aptly named... Read more

Findings from 'Melanoma Monday' at American Society of Clinical Oncologists (ASCO) annual meeting

Tuesday, June 3, 2014, 1:18 PM
I spent this past weekend in Chicago covering the American Society of Clinical Oncologists (ASCO) annual meeting. There are quite a number of follow up stories from the weekend that will be published over the next few weeks; but first, here is a quick recap from “Melanoma Monday,” which... Read more

A month-long adventure, all in the name of cancer

Friday, May 30, 2014, 10:15 AM
This spring has given me chance after chance to become much more ingrained in the melanoma community. The GSK Melanoma Blogger Symposium was just one stop in a month-long adventure that has taken me to six different states to talk about, learn about, write about, and mingle with those in the melanoma... Read more

3 similarities cancer bloggers share in their journeys, writings

Thursday, May 22, 2014, 3:52 PM
GlaxoSmithKline sponsored a Melanoma Blogger Symposium on Monday at their Navy Yard offices (which, if you haven’t seen, are pretty spectacular). Their goal, during Melanoma Awareness month, was to better understand how us blogger types communicate to our audience and, in turn, how GSK can better... Read more

Sharing my story for the benefit of others

Thursday, May 15, 2014, 2:47 PM
When you realize that your face is better suited for radio than TV, the obvious thing to do is avoid the camera as much as possible, right? Well, that hasn’t really been the case with certain melanoma patients recently. It started innocently enough with an advocate video telling my story for... Read more

The face of Melanoma has changed – literally

Tuesday, May 13, 2014, 9:54 AM
For one in every 10 patients getting PD-1, a curious-looking side effect brings us together with the King of Pop, mixed martial arts, America’s Top Models, and (sort of) Disney. As you can see, my face has changed, and it’s the result of vitiligo – the loss of pigmentation in the... Read more
About this blog
T.J. Sharpe is sharing his fight against Stage 4 Melanoma. A South Jersey native and Bishop Eustace graduate, he currently lives in Fort Lauderdale, FL with his wife Jennifer and children Josie and Tommy. He was Patient #1 in a clinical trial at Moffitt Cancer Center in Tampa as the first person worldwide to use this sequence of treatments to fight melanoma, and is currently in a second clinical trial at Holy Cross Hospital in Fort Lauderdale receiving Merck’s anti-PD-1 drug Lambrolizumab

The Patient #1 blog will update the progress of T.J.'s fight against cancer, and also touch on many cancer-related topics.

Follow T.J. on Twitter and Facebook. Reach T.J. at

T.J. Sharpe
Also on
Stay Connected